PT640098E - Gene de coronavirus canino e suas utilizacoesc - Google Patents

Gene de coronavirus canino e suas utilizacoesc

Info

Publication number
PT640098E
PT640098E PT93911346T PT93911346T PT640098E PT 640098 E PT640098 E PT 640098E PT 93911346 T PT93911346 T PT 93911346T PT 93911346 T PT93911346 T PT 93911346T PT 640098 E PT640098 E PT 640098E
Authority
PT
Portugal
Prior art keywords
canine coronavirus
coronavirus gene
gene
ccv
spike gene
Prior art date
Application number
PT93911346T
Other languages
English (en)
Inventor
Elaine Verne Jones
Timothy J Miller
Sharon Klepfer
Albert Paul Reed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT640098E publication Critical patent/PT640098E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT93911346T 1992-05-08 1993-05-07 Gene de coronavirus canino e suas utilizacoesc PT640098E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88019492A 1992-05-08 1992-05-08

Publications (1)

Publication Number Publication Date
PT640098E true PT640098E (pt) 2003-01-31

Family

ID=25375695

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93911346T PT640098E (pt) 1992-05-08 1993-05-07 Gene de coronavirus canino e suas utilizacoesc

Country Status (10)

Country Link
EP (1) EP0640098B1 (pt)
JP (1) JP3245169B2 (pt)
AT (1) ATE225805T1 (pt)
AU (1) AU670092B2 (pt)
CA (1) CA2135200C (pt)
DE (1) DE69332375T2 (pt)
DK (1) DK0640098T3 (pt)
ES (1) ES2182827T3 (pt)
PT (1) PT640098E (pt)
WO (1) WO1993023423A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2135201A1 (en) * 1992-05-08 1993-11-25 Timothy J. Miller Universal coronavirus vaccine
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
FR2828405B1 (fr) 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
GB0217434D0 (en) * 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
CN113583096B (zh) * 2020-05-01 2023-06-30 清华大学 SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用
CN112079906B (zh) * 2020-07-15 2022-11-04 张影 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒
CN113945714B (zh) * 2020-07-16 2023-01-31 南京蓬勃生物科技有限公司 新型冠状病毒中和抗体类药物中和能力的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264979A1 (en) * 1986-09-05 1988-04-27 Duphar International Research B.V New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
HUT45559A (en) * 1987-01-16 1988-07-28 Duphar Int Res Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
EP0510773B1 (en) * 1991-04-25 2003-12-17 Akzo Nobel N.V. Canine coronavirus subunit vaccine
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
CA2135201A1 (en) * 1992-05-08 1993-11-25 Timothy J. Miller Universal coronavirus vaccine

Also Published As

Publication number Publication date
WO1993023423A1 (en) 1993-11-25
EP0640098A1 (en) 1995-03-01
AU670092B2 (en) 1996-07-04
ATE225805T1 (de) 2002-10-15
DE69332375D1 (de) 2002-11-14
DE69332375T2 (de) 2003-02-13
EP0640098B1 (en) 2002-10-09
JP3245169B2 (ja) 2002-01-07
CA2135200A1 (en) 1993-11-25
CA2135200C (en) 2001-03-27
EP0640098A4 (en) 1997-01-02
AU4251593A (en) 1993-12-13
DK0640098T3 (da) 2002-10-28
JPH07508421A (ja) 1995-09-21
ES2182827T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
PE14199A1 (es) Agonistas de 5-ht1f
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
BR9908280A (pt) Inibidores de enzimas de fosfolipase
BR9812339A (pt) Processo para branquear os dentes, e, composição de higiene oral para branqueamento do dente
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
SE9802729D0 (sv) Novel Compounds
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
BRPI0407207A (pt) Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter
IL162917A0 (en) A lysin from bacteriophage and pharmaceutical compositions containing the same
ES2193919T3 (es) Inhibidores de la enzima convertidora de endotelina.
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
PT640098E (pt) Gene de coronavirus canino e suas utilizacoesc
SE9604348D0 (sv) Användning av hydroxyguanidiner
ES2180948T3 (es) Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal.
EP0387802A3 (en) 5-substituted-1,4-dihydro-4-oxonaphthyridine-3-carboxylate antibacterial agents
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
BR9811643A (pt) Suplementação quìmica de osso
ID25478A (id) Agonis 5-ht1f
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen